Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jeffrey Langsam currently holds 127,650 shares of Oncology Institute, Inc. (TOI), valued at approximately $0. This represents their equity stake as Chief Clinical Officer.
Based on SEC Form 4 filings, Jeffrey Langsam has been a net neutral trader of TOI stock. They have purchased $0 and sold $0 worth of shares.
Jeffrey Langsam's most recent insider trade was on Mar 27, 2026, when they sold 70,270 shares at $0.00 per share.
Jeffrey Langsam serves as Chief Clinical Officer at Oncology Institute, Inc. (TOI). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Jeffrey Langsam holds the position of Chief Clinical Officer at Oncology Institute, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Jeffrey Langsam has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Jeffrey Langsam was on Mar 27, 2026, when they purchased $0 worth of TOI shares. This transaction involved 70,270 shares at N/A per share.
Jeffrey Langsam currently owns 127,650 shares of Oncology Institute, Inc. (TOI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jeffrey Langsam's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jeffrey Langsam has 1 Form 4 filings on record as an insider at Oncology Institute, Inc..
Set alerts for Jeffrey Langsam and 40,000+ other insiders.